Up-regulation of stathmin induces growth arrest of esophageal squamous cell carcinoma EC9706 cell

National Medical Journal of China

Volumn 90, Issue 30, 2010, Pages 2140-2144

  Wang, Feng ^a   Wang, Liu Xing ^a   He, Wei ^a   Li, Ke ^a   Wang, Rui Lin ^a   Zhao, Pei Rong ^b   Fan, Qing Xia ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b NONE

Author keywords

Cell cycle; EC9706 cells; Esophageal neoplasms; Stathmin genes; Transfection

Indexed keywords

ANTINEOPLASTIC AGENT; COMPLEMENTARY DNA; LIPOFECTAMINE; STATHMIN;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENESIS; CELL COUNT; CELL CYCLE ARREST; CELL PROLIFERATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; EXPRESSION VECTOR; FLOW CYTOMETRY; GENETIC TRANSFECTION; IN VITRO STUDY; MOLECULAR CLONING; MORPHOLOGY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RECOMBINANT PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; ESOPHAGUS TUMOR; FEMALE; GENE VECTOR; GENETICS; HUMAN; METABOLISM; NUDE MOUSE; PLASMID; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; FEMALE; GENETIC VECTORS; HUMANS; MICE; MICE, NUDE; PLASMIDS; STATHMIN; TRANSFECTION; UP-REGULATION;

EID: 84871429367     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2010.30.014     Document Type: Article

References (16)

1. Rubin C I, Atweh G F. The role of stathmin in the regulation of the cell cycle. J Cell Biochem, 2004, 93:242-250.
2. Ghosh R, Gu G, Tillman E, et al. Increased expression and differential phosphorylation of stathmin may promote prostate cancer progression. Prostate, 2007, 67: 1038-1052.
3. Gan L, Guo K, Li Y, et al. Up-regulated expression of stathmin may be associated with hepatocarcinogenesis. Oncol Rep, 2010, 23:1037-1043.
4. Ringhoff D N, Cassimeris L. Stathmin regulates centrosomal nucleation of microtubules and tubulin dimer/polymer partitioning. Mol Biol Cell, 2009, 20: 3451-3458.
5. Rana S, Maples P B, Senzer N, et al. Stathmin 1: a novel therapeutic target for anticancer activity. Expert Rev Anticancer Ther, 2008, 8:1461-1470.
6. Kouzu Y, Uzawa K, Koike H, et al. Overexpression of stathmin in oral squamous- cell carcinoma: correlation with tumour progression and poor prognosis. Br J Cancer, 2006, 94:717-723.
7. Seve P, Dumontet C. Chemoresistance in non-small cell lung cancer. Curr Med Chem Anticancer Agents, 2005, 5:73-88.
8. Misek D E, Chang C L, Kuick R, et al. Transforming properties of a Q18-> E mutation of the microtubule regulator Op18. Cancer Cell, 2002, 2: 217-228.
9. 2007, 20:372-374.
10. 2002.
11. 2006, 86: 1564-1567.
12. 2005, 85: 3229-3231.
13. Kim J Y, Harvard C, You L, et al. Stathmin is overexpressed in malignant mesothelioma. Anticancer Res, 2007, 27:39-44.
14. Manna T, Thrower D A, Honnappa S, et al. Regulation of microtubule dynamic instability in vitro by differentially phosphorylated stathmin. J Biol Chem, 2009, 284:15640-15649.
15. Wang R, Dong K, Lin F, et al. Inhibiting Proliferation and Enhancing Chemosensitivity to Taxanes in Osteosarcoma Cells by RNA Interference-Mediated Downregulation of Stathmin Expression. Mol Med, 2007, 13: 567-575.
16. Alli E, Yang J M, Ford J M, et al. Reversal of stathmin-mediated resistance to paclitaxel and vinblastine in human breast carcinoma cells. Mol Pharmacol, 2007, 71:1233-1240.